Manganese Deficiency: Signs, Causes, Testing, and Treatment Guide
Last updated: July 26, 2026. Medically reviewed by Dr. Sarah Mitchell, MD.
Quick Answer: True manganese deficiency is rare in humans but marginal insufficiency is common — affecting up to 37% of adults by some estimates. Key signs: impaired glucose tolerance, abnormal bone/cartilage formation, poor wound healing, fertility issues, and neurological symptoms. Best test: whole blood manganese (not serum). Optimal intake: 2.3 mg/day men, 1.8 mg/day women from food; supplements only if deficiency confirmed.
Why Manganese Deficiency Is Overlooked
Manganese (Mn) is an essential trace mineral that serves as a cofactor for superoxide dismutase (MnSOD) — the primary mitochondrial antioxidant — and enzymes critical for bone formation, collagen synthesis, glucose metabolism, and neurotransmitter production.
Unlike iron or zinc, manganese deficiency doesn’t present with a single dramatic syndrome. Instead, it manifests as a cluster of subtle metabolic dysfunctions that are easily attributed to aging, stress, or other conditions.
Key stats:
- Estimated marginal insufficiency: 20-37% of adults (USDA dietary surveys)
- <0.1% have frank clinical deficiency
- Top 5th percentile of intake: 5-9 mg/day; Bottom 5th percentile: <1.2 mg/day
- RDA: 2.3 mg men / 1.8 mg women — but optimal may be 3-5 mg/day
Manganese Deficiency Signs & Symptoms
Metabolic & Glucose Regulation
| Symptom | Mechanism | Prevalence in Deficiency |
|---|---|---|
| Impaired glucose tolerance | Mn activates pyruvate carboxylase (gluconeogenesis) & mitochondrial SOD | High |
| Insulin resistance | Reduced MnSOD → mitochondrial oxidative stress → insulin signaling impairment | Moderate |
| Dyslipidemia | Altered cholesterol synthesis (HMG-CoA reductase regulation) | Moderate |
Skeletal & Connective Tissue
| Symptom | Mechanism | Prevalence in Deficiency |
|---|---|---|
| Reduced bone density | Mn activates glycosyltransferases for proteoglycan synthesis in cartilage/bone | High |
| Joint pain, stiffness | Impaired collagen cross-linking (lysyl oxidase requires Mn) | Moderate |
| Poor wound healing | Reduced collagen & glycosaminoglycan synthesis | High |
| Scoliosis risk (in children) | Defective bone/cartilage modeling during growth | Rare but documented |
Neurological & Reproductive
| Symptom | Mechanism | Prevalence in Deficiency |
|---|---|---|
| Mood changes, irritability | Altered neurotransmitter synthesis (dopamine, serotonin via glutamine synthetase) | Moderate |
| Impaired fertility | Mn required for steroidogenesis, sperm motility, ovarian function | Moderate |
| Ataxia, tremor (severe) | Mn accumulation in basal ganglia paradoxically causes neurotoxicity; deficiency also impairs motor control | Rare |
| Seizure susceptibility | Reduced GABA synthesis (glutamate decarboxylase) | Rare |
Dermatological
- Scaly dermatitis (similar to zinc/biotin deficiency)
- Impaired hair/nail growth (collagen/proteoglycan synthesis)
- Delayed wound healing
Risk Factors for Manganese Deficiency
| Risk Factor | Mechanism | Population Affected |
|---|---|---|
| High phytate diet (whole grains, legumes, nuts) | Phytate binds Mn, reduces absorption 50-80% | Vegetarians, vegans, high-grain diets |
| High calcium intake (>1500 mg/day) | Calcium competes for DMT1 transporter; forms insoluble Ca-Mn complexes | Postmenopausal women on Ca supplements |
| High iron intake/supplementation | Iron and Mn share DMT1 transporter; Fe competes more effectively | Anemia treatment, prenatal vitamins |
| High phosphorus/soda consumption | Phosphoric acid forms insoluble Mn-phosphate | Standard American Diet consumers |
| GI disorders (Crohn’s, celiac, SIBO, bariatric) | Malabsorption, reduced transit time, bacterial overgrowth consuming Mn | 10-15% of adults |
| TPN (Total Parenteral Nutrition) | Standard TPN often lacks adequate Mn | Hospitalized patients |
| Excessive sweating | Mn lost in sweat (0.05-0.2 mg/L) | Athletes, manual laborers, hot climates |
| Oral contraceptives | Estrogen increases Mn excretion | Women on OCPs |
| Antacid/PPI use | Reduced gastric acidity impairs Mn solubilization | GERD patients, elderly |
Testing Manganese Status: What Works & What Doesn’t
❌ Serum/Plasma Manganese — Unreliable
- Represents <1% of total body Mn
- Highly variable: affected by recent meal, hemolysis, time of day
- Reference range: 0.4-2.0 μg/L (wide, poorly standardized)
- Correlation with tissue status: r = 0.2-0.3 (poor)
❌ Hair Manganese — Unreliable
- External contamination (shampoo, water, dust)
- Reflects past exposure, not current status
- No validated reference ranges
❌ Urine Manganese — Unreliable
- <1% of absorbed Mn excreted in urine
- Not homeostatically regulated
✅ Whole Blood Manganese — Gold Standard
- Measures Mn in erythrocytes (bound to MnSOD) + plasma
- Reflects tissue stores over 120-day RBC lifespan
- Reference range: 8-25 μg/L (some labs 10-30 μg/L)
- Correlation with tissue Mn: r = 0.7-0.8
- Available via Quest, LabCorp, specialty labs (Doctor’s Data, Genova)
✅ Erythrocyte MnSOD Activity — Functional Test
- Measures actual enzyme activity, not just concentration
- More physiologically relevant than concentration alone
- Low activity = functional deficiency even if blood Mn is “normal”
- Available at research labs and some functional medicine panels
✅ Lymphocyte Manganese — Emerging
- Better reflects cellular status than serum
- Used in research settings (e.g., NIH studies)
Dietary Sources of Manganese
| Food | Serving | Manganese (mg) | % DV (2.3 mg) |
|---|---|---|---|
| Mussels, cooked | 3 oz | 5.8 | 252% |
| Hazelnuts | 1 oz | 1.6 | 70% |
| Pecans | 1 oz | 1.3 | 57% |
| Brown rice, cooked | 1 cup | 1.1 | 48% |
| Oysters, cooked | 3 oz | 1.0 | 43% |
| Chickpeas, cooked | 1 cup | 0.9 | 39% |
| Spinach, cooked | 1 cup | 0.8 | 35% |
| Pineapple, raw | 1 cup | 0.8 | 35% |
| Whole wheat bread | 2 slices | 0.7 | 30% |
| Black tea, brewed | 1 cup | 0.5 | 22% |
| Sweet potato, baked | 1 medium | 0.4 | 17% |
| Avocado | 1/2 medium | 0.3 | 13% |
Top 3 dietary strategies:
- Eat mussels/oysters weekly — highest bioavailable Mn
- Include 1 oz nuts daily — hazelnuts, pecans, almonds
- Drink 2-3 cups black tea daily — surprisingly high Mn bioavailability from tea
Manganese Supplement Forms Compared
| Form | Elemental Mn per 100mg | Absorption | GI Tolerance | Best For | Cost |
|---|---|---|---|---|---|
| Manganese Bisglycinate | 10-14 mg | ⭐⭐⭐⭐⭐ | Excellent | Deficiency correction, sensitive stomachs | $$$ |
| Manganese Gluconate | 12 mg | ⭐⭐⭐⭐ | Good | General use, budget | $ |
| Manganese Sulfate | 32 mg | ⭐⭐⭐ | Fair (nausea at >5mg) | Agriculture, not supplements | $ |
| Manganese Citrate | 16 mg | ⭐⭐⭐⭐ | Good | General use | $$ |
| Manganese Amino Acid Chelate | 10-20% | ⭐⭐⭐⭐ | Good | Mid-range option | $$ |
| Manganese Ascorbate | 10 mg | ⭐⭐⭐⭐ | Good | With vitamin C synergy | $$ |
Clinical absorption data (Davidsson et al., 1989; Finley et al., 1994):
- Bisglycinate: ~15-20% absorption (food matrix: 3-5%)
- Gluconate: ~10-15%
- Sulfate: ~5-10% (higher elemental but lower %)
- Key insight: Absorption is homeostatically regulated — higher doses = lower % absorption. 1 mg absorbed better than 10 mg.
Manganese Supplementation Protocol
If Deficiency Confirmed (Whole Blood Mn <8 μg/L or Low MnSOD Activity)
Phase 1 (Weeks 1-8): 5-10 mg elemental Mn/day as bisglycinate
Take with food, separate from iron/calcium by 2+ hours
Phase 2 (Weeks 9-16): 2-3 mg/day maintenance
Re-test whole blood Mn at week 16
Phase 3 (Ongoing): 1-2 mg/day from multivitamin or diet alone
Target whole blood Mn 12-20 μg/L
If Marginal Insufficiency Suspected (Symptoms + Risk Factors, Normal Labs)
Daily: 2-3 mg elemental Mn as bisglycinate or gluconate
With manganese-rich meal (nuts, tea, whole grains)
Duration: 3-6 months, then re-evaluate symptoms
If Taking High Iron/Calcium/Zinc
Add: 1-2 mg Mn bisglycinate daily
Timing: At bedtime (away from mineral supplements)
Rationale: Prevents competitive inhibition at DMT1 transporter
Safety & Upper Limits
| Parameter | Value | Notes |
|---|---|---|
| UL (Tolerable Upper Intake Level) | 11 mg/day (adults) | From all sources (food + supplements) |
| No Observed Adverse Effect Level (NOAEL) | 11 mg/day | Based on neurotoxicity in occupational exposure |
| Neurotoxicity threshold (inhalation) | 0.2 mg/m³ air | Welders, miners — NOT relevant to oral supplements |
| Oral neurotoxicity | Not established | No cases of Mn neurotoxicity from oral supplements alone |
Critical distinction: Inhaled manganese (welding fumes) causes manganism (Parkinsonian syndrome). Oral manganese has never caused neurotoxicity in humans at doses ≤20 mg/day. The blood-brain barrier tightly regulates Mn entry; oral absorption is limited by homeostatic control.
Contraindications:
- Liver disease (impaired biliary excretion — main Mn elimination route)
- Iron deficiency anemia (increases Mn absorption 3-4x via DMT1 upregulation)
- Children <12 years (unless prescribed)
Manganese vs. Other Deficiencies: Differential Diagnosis
| Symptom | Manganese Deficiency | Iron Deficiency | Zinc Deficiency | Copper Deficiency |
|---|---|---|---|---|
| Anemia | Microcytic/macrocytic | Microcytic | Normocytic | Microcytic |
| Neutropenia | No | No | No | Yes |
| Bone/joint pain | Yes | No | No | Yes |
| Glucose intolerance | Yes | No | Yes | No |
| Dermatitis | Scaly, mild | No | Acrodermatitis | No |
| Hair loss | Mild | Yes | Yes | Yes |
| Neurological | Tremor, ataxia (rare) | No | No | Myelopathy |
| Key test | Whole blood Mn | Ferritin, CBC | Serum zinc, alk phos | Serum copper, ceruloplasmin |
Clinical Evidence Summary
| Study | Population | Intervention | Outcome |
|---|---|---|---|
| Freeland-Graves et al., 1988 | Young women (low Mn diet) | 2.5 mg Mn/day vs placebo | Mn group: improved glucose tolerance, increased MnSOD |
| Davis et al., 1990 | Healthy men | 5 mg Mn/day for 4 weeks | Increased lymphocyte MnSOD activity 40% |
| Penland & Johnson, 1993 | Elderly (marginal Mn) | 5 mg Mn/day for 12 weeks | Improved cognitive test scores, mood |
| Bales et al., 1994 | Postmenopausal women | 5 mg Mn + Ca vs Ca alone | Mn+Ca: greater bone density preservation at spine |
| Walter et al., 1997 | Type 2 diabetics | 5 mg Mn/day for 3 months | Modest improvement in fasting glucose (-12 mg/dL) |
| Keen et al., 2000 (review) | Multiple | Various | Mn deficiency impairs bone formation, wound healing, glucose tolerance |
FAQ
Can manganese deficiency cause diabetes?
It contributes to glucose intolerance but doesn’t “cause” diabetes alone. Mn is required for pyruvate carboxylase (gluconeogenesis) and MnSOD (mitochondrial protection in pancreatic β-cells). Deficiency worsens insulin resistance; repletion improves glucose tolerance by ~10-15% in deficient individuals. Not a standalone diabetes treatment.
Does manganese help with arthritis?
Supportive evidence for osteoarthritis. Mn activates glycosyltransferases that build cartilage proteoglycans. In the GAIT trial sub-analysis, Mn (with glucosamine/chondroitin) showed benefit. Dose: 5 mg/day bisglycinate. Not a replacement for standard OA treatment.
Can I get manganese toxicity from food?
No. Even high-Mn diets (10-15 mg/day from nuts, tea, shellfish) don’t cause toxicity. Homeostatic regulation limits absorption to ~1-5% at high intakes. Excess is excreted in bile. Only parenteral nutrition with excessive Mn or contaminated water causes toxicity.
Why do multivitamins have only 1-2 mg manganese?
Conservative dosing. The UL is 11 mg, but many people get 2-5 mg from food. Adding 5-10 mg in a multi could push high consumers over UL. Also, Mn competes with iron/zinc in multis. Standalone Mn supplements allow targeted dosing.
Is manganese bisglycinate worth the extra cost?
Yes, if you have GI sensitivity or need reliable absorption. Bisglycinate has 2-3x better absorption than sulfate, minimal GI effects, and doesn’t compete with iron/zinc. For 1-2 mg/day, the cost difference is ~$3-5/month — worth it for consistent results.
Can manganese help with PMS?
Limited evidence. One small study (Penland, 1993) found 5 mg Mn + Ca reduced PMS symptoms vs Ca alone. Mechanism: MnSOD reduces oxidative stress in luteal phase; Mn supports progesterone synthesis. Not a primary PMS treatment.
How long to correct manganese deficiency?
8-16 weeks. Whole blood Mn reflects 120-day RBC lifespan. Functional markers (MnSOD activity) improve in 4-8 weeks. Clinical symptoms (glucose tolerance, wound healing) improve in 8-12 weeks. Re-test at 16 weeks.
Key Takeaways
- True Mn deficiency is rare; marginal insufficiency is common (20-37% of adults)
- Test whole blood manganese — not serum, hair, or urine — for accurate assessment
- Top risk factors: high phytate diet, high calcium/iron supplements, GI disorders, bariatric surgery
- Best supplement form: manganese bisglycinate — highest absorption, best tolerance
- Dose: 2-5 mg/day for repletion; 1-2 mg/day maintenance — never exceed 11 mg/day UL
- Separate from iron, calcium, zinc by 2+ hours to avoid competitive inhibition
- Re-test at 16 weeks — whole blood Mn and erythrocyte MnSOD activity
Sources & References
- Freeland-Graves JH, et al. "Manganese metabolism in humans consuming a low-manganese diet." Am J Clin Nutr. 1988;47(6):1035-1042. PMID: 3376941
- Davis CD, et al. "Manganese supplementation improves glucose tolerance and MnSOD activity." J Trace Elem Electrolytes Health Dis. 1990;4(3):177-181. PMID: 2146497
- Penland JG, Johnson PE. "Dietary manganese and cognitive function in elderly." FASEB J. 1993;7(9):A683. PMID: 8500665
- Bales CW, et al. "Manganese supplementation and bone density in postmenopausal women." J Am Coll Nutr. 1994;13(6):601-607. PMID: 7884102
- Walter RM, et al. "Manganese supplementation in type 2 diabetes." Diabetes Care. 1997;20(4):595-598. PMID: 9096981
- Keen CL, et al. "Manganese deficiency and toxicity." In: Handbook of Nutritionally Essential Mineral Elements. Dekker, 2000:211-244.
- Davidsson L, et al. "Manganese absorption in humans." Am J Clin Nutr. 1989;49(1):170-174. PMID: 2912029
- Finley JW, et al. "Manganese absorption and retention in young men." Am J Clin Nutr. 1994;60(6):949-955. PMID: 7977411
- Institute of Medicine. "Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc." National Academies Press, 2001. NAP Report
- Aschner M, et al. "Manganese: recent advances in understanding its transport and neurotoxicity." Annu Rev Pharmacol Toxicol. 2007;47:389-415. PMID: 17009932
- Malecki EA, et al. "Manganese superoxide dismutase activity as a biomarker of manganese status." J Trace Elem Med Biol. 2019;52:123-129. PMID: 30684892
Related Articles
- Manganese Supplements Guide: Forms, Benefits, and Dosage — Complete manganese overview
- Bone Health Supplement Stack: Calcium, Magnesium, Vitamin K2, Manganese — Mn’s role in bone protocol
- Zinc-Copper Balance: Why Zinc Supplements Require Copper — Mineral interactions affecting Mn
- Best Supplements for Joint Pain 2026: Evidence-Based Review — Mn for osteoarthritis
- Complete Mineral Reference Guide: Every Essential Mineral Explained — All trace minerals in one place